You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyroid Orbitopathy

Showing 1 - 25 of 1,602
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

Completed
  • Thyroid Associated Orbitopathy
  • Cairo, Egypt
    Cairo University
Jul 15, 2022

Clinical Activity of TAO Using Periocular Images Taken by

Completed
  • Thyroid Eye Disease
  • taking periorbital selfie images using smartphones
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    Seoul National University Bundang Hospital
Feb 15, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Graves Orbitopathy
  • Essen, Germany
  • +6 more
Jul 14, 2022

Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)

Completed
Has Results
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Placebo
  • Beverly Hills, California
  • +13 more
Jan 31, 2022

Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

Recruiting
  • Graves Ophthalmopathy
  • +2 more
  • Simvastatin 40mg
  • Malmö, Sweden
    Dpt. of Endocrinology, SUS Malmö
Nov 17, 2021

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Beverly Hills, California
  • +22 more
Jan 30, 2023

Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)

Completed
  • Thyroid Associated Ophthalmopathy
  • Hypercholesterolemia
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology I and II
Aug 12, 2021

Graves Ophthalmopathy Trial in Newcastle upon Tyne (Otelixizumab - low dose, Otelixizumab - medium low dose, Otelixizumab -

Terminated
Has Results
  • Graves Ophthalmopathy
  • Otelixizumab - low dose
  • +5 more
  • Newcastle upon Tyne, United Kingdom
    GSK Investigational Site
Oct 8, 2020

Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)

Completed
Has Results
  • Thyroid Eye Disease
  • Teprotumumab
  • Beverly Hills, California
  • +12 more
Dec 9, 2021

Thyroid Associated Ophthalmopathy Trial (Orbital radiotherapy, Methylprednisolone)

Not yet recruiting
  • Thyroid Associated Ophthalmopathy
  • (no location specified)
Mar 24, 2020

Graves Ophthalmopathy Trial in Taipei (Hydroxychloroquine)

Recruiting
  • Graves Ophthalmopathy
  • Hsinchu, Taiwan
  • +1 more
Dec 1, 2022

Thyroid Orbitopathy Trial (Selenium, Placebo)

Completed
  • Thyroid Orbitopathy
  • Selenium
  • Placebo
  • (no location specified)
Mar 25, 2019

Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

Completed
  • Graves Ophthalmopathy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 29, 2023

Customized Multiple Orbital Wall Decompression for

Recruiting
  • Thyroid Eye Disease
  • Modified multiple orbital wall decompression
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Nov 17, 2022

Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

Not yet recruiting
  • Thyroid Eye Disease
  • VRDN-001 10 mg/kg Drug:
  • (no location specified)
Sep 7, 2023

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Graves Ophthalmopathy Trial in Pisa (Sirolimus)

Not yet recruiting
  • Graves Ophthalmopathy
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
Nov 2, 2022

Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)

Approved for marketing
  • Thyroid Eye Disease
  • Graves' Orbitopathy
  • Teprotumumab
  • Beverly Hills, California
  • +7 more
Mar 13, 2020

Exophthalmos, Orbitopathy, Graves, Surgery Trial (Orbital decompression with ultrasonic bone removal)

Completed
  • Exophthalmos
  • +2 more
  • Orbital decompression with ultrasonic bone removal
  • (no location specified)
Jul 18, 2019

Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)

Withdrawn
  • Thyroid Associated Ophthalmopathies
  • Sodium selenate
  • Sugar pill
  • (no location specified)
Aug 12, 2021

Graves Orbitopathy Trial in Katowice (rabbit anti-thymocyte globulin)

Recruiting
  • Graves Orbitopathy
  • rabbit anti-thymocyte globulin
  • Katowice, Silesia, Poland
    Department of Internal Medicine and Oncological Chemotherapy, Me
Jan 14, 2022

Thyroid Eye Disease Trial in Los Angeles (Hyaluronic Acid Gel injection, Saline injection)

Terminated
  • Thyroid Eye Disease
  • Hyaluronic Acid Gel injection
  • Saline injection
  • Los Angeles, California
  • +1 more
Sep 27, 2021

Graves' Disease Trial (Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg)

Not yet recruiting
  • Graves' Disease
  • Mycophenolate Mofetil, Oral, 250 Mg
  • methimazole, oral, 10mg
  • (no location specified)
Sep 28, 2023

Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

Not yet recruiting
  • Thyroid-Associated Ophthalmopathy
  • (no location specified)
Mar 18, 2022